Related Experiment Video

Updated: Jan 7, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

7.3K

Recovery of HBV-specific B cell function after discontinuation of nucleos(t)ide analogue therapy: new insight and

Antonio Bertoletti1, Shubhankar Sunil Ambike2

  • 1Duke-NUS Medical School, Singapore antonio@duke-nus.edu.sg.

Gut
|January 2, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
CHRONIC VIRAL HEPATITIS

More Related Videos

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

3.4K
Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

16.2K

Related Experiment Videos

Last Updated: Jan 7, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

7.3K
Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

3.4K
Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

16.2K

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

1.6K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.6K

Articles linked to this work by shared authors, journal, and citation graph.

Sex-specific trajectories of nonlinear immune aging at single-cell level.

Nature communications·2026

DC subsets and states unraveled across human juxtatumoral and malignant tissues.

Nature immunology·2025

Decoding HBV-specific adaptive immunity: from natural clearance to cure.

Gut·2025

CD4+ T cells license Kupffer cells to reverse CD8+ T cell dysfunction induced by hepatocellular priming.

Nature immunology·2025

Vaccine-induced T cell responses control Orthoflavivirus challenge infection without neutralizing antibodies in humans.

Nature microbiology·2025

A rapid method to assess the in vivo multi-functionality of adoptively transferred engineered TCR T cells.

Immunotherapy advances·2024

Butyrylcholinesterase alleviates hepatic stellate cell activation via paracrine muscarinic signalling.

Gut·2026

Integrative multi-omics landscape and diagnostic-therapeutic modelling of steatohepatitic hepatocellular carcinoma.

Gut·2026

Hospitalisation in cirrhosis is linked to distinct gut microbiome structural and functional profiles: a multinational metagenomic study.

Gut·2026

Prior endoscopic surveillance and diagnosis of Barrett-related dysplasia and cancer: evidence from a nationwide Dutch cohort.

Gut·2026

Eosinophilic gastritis: burden of disease, diagnostic challenges and unmet needs.

Gut·2026

Coordinated cellular programmes distinguish responses to neoadjuvant PD-L1 blockade and potentiate combinatorial immunotherapy in ESCC.

Gut·2026

Altered m 6 A methylation across eight reward- and motor-related brain regions in alcohol use disorder.

medRxiv : the preprint server for health sciences·2026

From vivarium to NAM-centred laboratory: A practical framework for managing infrastructure, expertise and organisational transition.

NAM journal·2026

Near real-time data on the human neutralizing antibody landscape to influenza virus in summer of 2026 shows antigenic advance of H3N2 subclade K region D mutants and H1N1 D.3.1.1 Sa mutants.

bioRxiv : the preprint server for biology·2026

P5 promoter-mediated incorporation explains REP/CAP manufacturing contaminants in patient liver after rAAV gene therapy.

medRxiv : the preprint server for health sciences·2026

Spatiotemporal control of STING activation and saRNA delivery decouples humoral and cellular immunity.

bioRxiv : the preprint server for biology·2026

Development and Optimisation Using D-Optimal Design of Dual-Functionalized Hyaluronic Acid-Chitosan-Coated Mesoporous Silica Nanoparticles for Repurposed Propranolol Delivery in Breast Cancer: A Proof-of-Concept Study.

Pharmaceutical development and technology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us